| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d007df0e92f4a5cb4c6420e2c4309c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e4c2f6cb99d3ac2aa25080678aa0da9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate |
2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d98400656b218477f17fc113b60edb8 |
| publicationDate |
2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015138186-A2 |
| titleOfInvention |
Methods and compositions for treating anthracycline-induced cardiomyopathy using neurokinin-1 receptor antagonists |
| abstract |
The presently disclosed subject matter provides methods and compositions for the treatment of anthracycline-induced cardiomyopathy, particularly doxorubicin- induced cardiomyopathy, using neurokinin-1 (NK-1) receptor antagonists. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017136774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2743433-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806716-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108697646-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017214668-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874633-B2 |
| priorityDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |